These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 31487202)

  • 1. Recent advances in the diagnosis and treatment of natural killer/T-cell lymphomas.
    Tse E; Au-Yeung R; Kwong YL
    Expert Rev Hematol; 2019 Nov; 12(11):927-935. PubMed ID: 31487202
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnosis and management of extranodal NK/T cell lymphoma nasal type.
    Tse E; Kwong YL
    Expert Rev Hematol; 2016 Sep; 9(9):861-71. PubMed ID: 27347812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How we treat NK/T-cell lymphomas.
    Tse E; Zhao WL; Xiong J; Kwong YL
    J Hematol Oncol; 2022 Jun; 15(1):74. PubMed ID: 35659326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnosis and management of NK/T-cell lymphomas.
    Tse E; Kwong YL
    J Hematol Oncol; 2017 Apr; 10(1):85. PubMed ID: 28410601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and management of natural killer-cell malignancies.
    Ishida F; Kwong YL
    Expert Rev Hematol; 2010 Oct; 3(5):593-602. PubMed ID: 21083476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnosis and management of extranodal NK/T-cell lymphoma, nasal-type and aggressive NK-cell leukemia.
    Kwong YL
    J Clin Exp Hematop; 2011; 51(1):21-8. PubMed ID: 21628857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NK/T-cell lymphomas.
    Tse E; Kwong YL
    Best Pract Res Clin Haematol; 2019 Sep; 32(3):253-261. PubMed ID: 31585625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus-associated natural killer/T-cell lymphomas.
    Asano N; Kato S; Nakamura S
    Best Pract Res Clin Haematol; 2013 Mar; 26(1):15-21. PubMed ID: 23768637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pralatrexate as a bridge to allogeneic hematopoietic stem cell transplantation in a patient with advanced-stage extranodal nasal-type natural killer/T cell lymphoma refractory to first-line chemotherapy: a case report.
    Liu YC; Lin TA; Wang HY; Ko PS; Liu CJ; Hsiao LT; Chien SH; Gau JP
    J Med Case Rep; 2020 Mar; 14(1):43. PubMed ID: 32183896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extranodal natural killer/T-cell lymphoma: advances in the management.
    Jaccard A; Hermine O
    Curr Opin Oncol; 2011 Sep; 23(5):429-35. PubMed ID: 21743325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How I treat NK/T-cell lymphomas.
    Tse E; Kwong YL
    Blood; 2013 Jun; 121(25):4997-5005. PubMed ID: 23652805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practical management of natural killer/T-cell lymphoma.
    Tse E; Kwong YL
    Curr Opin Oncol; 2012 Sep; 24(5):480-6. PubMed ID: 22691924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the treatment of extranodal NK/T-cell lymphoma, nasal type.
    Yamaguchi M; Suzuki R; Oguchi M
    Blood; 2018 Jun; 131(23):2528-2540. PubMed ID: 29602763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia.
    Yamaguchi M; Suzuki R; Kwong YL; Kim WS; Hasegawa Y; Izutsu K; Suzumiya J; Okamura T; Nakamura S; Kawa K; Oshimi K
    Cancer Sci; 2008 May; 99(5):1016-20. PubMed ID: 18294294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A five
    Vittayawacharin P; Khuhapinant A
    Hematology; 2021 Dec; 26(1):75-82. PubMed ID: 33427594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of advanced NK/T-cell lymphoma.
    Tse E; Kwong YL
    Curr Hematol Malig Rep; 2014 Sep; 9(3):233-42. PubMed ID: 24924658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-asparaginase-based treatment of 15 western patients with extranodal NK/T-cell lymphoma and leukemia and a review of the literature.
    Jaccard A; Petit B; Girault S; Suarez F; Gressin R; Zini JM; Coiteux V; Larroche C; Devidas A; Thiéblemont C; Gaulard P; Marin B; Gachard N; Bordessoule D; Hermine O
    Ann Oncol; 2009 Jan; 20(1):110-6. PubMed ID: 18701429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Advances in the Diagnosis and Treatment of Natural Killer Cell Malignancies.
    Tse E; Kwong YL
    Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/II NK/T-cell lymphoma.
    Kwong YL; Kim SJ; Tse E; Oh SY; Kwak JY; Eom HS; Do YR; Mun YC; Lee SR; Shin HJ; Suh C; Chuang SS; Lee YS; Lim ST; Izutsu K; Suzuki R; Relander T; d'Amore F; Schmitz N; Jaccard A; Kim WS
    Ann Oncol; 2018 Jan; 29(1):256-263. PubMed ID: 29077846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk stratification in extranodal natural killer/T-cell lymphoma.
    Kohrt H; Lee M; Advani R
    Expert Rev Anticancer Ther; 2010 Sep; 10(9):1395-405. PubMed ID: 20836675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.